Beruflich Dokumente
Kultur Dokumente
PHASE IV
Phase IV are post marketing studies and provide
basis for continued marketing. They may also
provide information to amend the package inserts
in terms of safety, precautions etc.
Phase IV studies provide additional data on safety
which may lead to safer use of the drug
OBJECTIVE
Determine the behaviour of the drug when used in
real life situation without the dietary control and the
control of commonly used items like nicotine and
alcohol.
Determine if at all any missed rare adverse reaction
or adverse reaction coming in late.
To evaluate the action of the drug in a situation
missed dosage or “over dosage”.
Regulatory Requirements
Permission of Drugs Controller General (India)
Can be obtained for these studies
The Drugs and Cosmetics Act does not specify that such
a permission is required.
Approval of the Institute Review Board
Itis being hotly debated
So far DCGI has not demanded IRB clearance for these
studies.
STUDY POPULATION
May be conducted in clinics, hospitals and private
practice
All patients with target disorder, but with greater
heterogeneity
Include all types of patients for whom the drug may
be indicated
I/E CRITERIA
Inclusion criteria to specify
Gender, age range of patients
Diagnosis to conform with target indication
Patients giving informed consent
Quality of life